DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE has floated a tender for Prescription Drug Abuse (Clinical Trial Optional). The project location is South Sudan and the tender is closing on 07 May 2019. The tender notice number is PA-18-058, while the TOT Ref Number is 18057285. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : South Sudan

Summary : Prescription Drug Abuse (Clinical Trial Optional)

Deadline : 07 May 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 18057285

Document Ref. No. : PA-18-058

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE
9609 Medical Center Drive, Room 1E128 Rockville - 20852
South Sudan

Tender Details

Tenders are invited for Prescription Drug Abuse (R01 Clinical Trial Optional).

Bid Date & Time: 05/07/19

Scope: This Funding Opportunity Announcement (FOA) encourages applicants to develop innovative research applications on prescription drug abuse, including research to examine the factors contributing to prescription drug abuse; to characterize the adverse medical, mental health and social consequences associated with prescription drug abuse; and to develop effective prevention and service delivery approaches and behavioral and pharmacological treatments. Applications to address these issues are encouraged across a broad range of methodological approaches including basic science, clinical, epidemiological, and health services research to define the extent of the problem of prescription drug abuse, to characterize this problem in terms of classes of drugs abused and combinations of drug types, etiology of abuse, and populations most affected (including analyses by age group, race/ethnicity, gender, and psychiatric symptomatology). Studies on individual- and patient-level factors, prescriber factors, and/or health system factors are encouraged, as are studies on all classes of prescription drugs with high abuse liability, including analgesics, stimulants, sedative/hypnotics and anxiolytics. Researchers are further encouraged to study the relationship between the prescription medication, the indication for which the medication was prescribed (e.g., pain, sleep disorder, anxiety disorder, obesity), and the environmental and individual factors contributing to abuse.

Location: Rockville

Documents

 Tender Notice